| Early-onset stroke and vasculopathy associated with mutations in ADA2 Q Zhou, D Yang, AK Ombrello, AV Zavialov, C Toro, AV Zavialov, ... New England Journal of Medicine 370 (10), 911-920, 2014 | 809 | 2014 |
| Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug‐induced, and inflammatory liver diseases S Bala, J Petrasek, S Mundkur, D Catalano, I Levin, J Ward, H Alao, ... Hepatology 56 (5), 1946-1957, 2012 | 708 | 2012 |
| Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection S Bala, Y Tilahun, O Taha, H Alao, K Kodys, D Catalano, G Szabo Journal of translational medicine 10, 1-10, 2012 | 176 | 2012 |
| Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome FL Kuang, F Legrand, M Makiya, JA Ware, L Wetzler, T Brown, T Magee, ... New England Journal of Medicine 380 (14), 1336-1346, 2019 | 164 | 2019 |
| Cellular microRNA networks regulate host dependency of hepatitis C virus infection Q Li, B Lowey, C Sodroski, S Krishnamurthy, H Alao, H Cha, S Chiu, ... Nature communications 8 (1), 1789, 2017 | 78 | 2017 |
| The spectrum of the deficiency of adenosine deaminase 2: an observational analysis of a 60 patient cohort KS Barron, I Aksentijevich, NT Deuitch, DL Stone, P Hoffmann, ... Frontiers in immunology 12, 811473, 2022 | 48 | 2022 |
| Baseline intrahepatic and peripheral innate immunity are associated with hepatitis C virus clearance during direct‐acting antiviral therapy H Alao, M Cam, C Keembiyehetty, F Zhang, E Serti, D Suarez, H Park, ... Hepatology 68 (6), 2078-2088, 2018 | 42 | 2018 |
| Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy RD Guber, V Takyar, A Kokkinis, DA Fox, H Alao, I Kats, D Bakar, ... Neurology 89 (24), 2481-2490, 2017 | 37 | 2017 |
| APECED‐associated hepatitis: clinical, biochemical, histological and treatment data from a large, predominantly American cohort DM Chascsa, EMN Ferré, Y Hadjiyannis, H Alao, M Natarajan, ... Hepatology 73 (3), 1088-1104, 2021 | 32 | 2021 |
| Single-organ and multisystem hypereosinophilic syndrome patients with gastrointestinal manifestations share common characteristics FL Kuang, BF Curtin, H Alao, B Piligian, A Berry, N Holland-Thomas, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2718-2726. e2, 2020 | 18 | 2020 |
| Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma G Ben‐Yakov, H Alao, JP Haydek, N Fryzek, MH Cho, M Hemmati, ... Hepatology communications 3 (2), 220-226, 2019 | 12 | 2019 |
| Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease‐could we strike while the liver is hard? G Ben Yakov, D Sharma, H Alao, P Surana, D Kapuria, O Etzion, ... British journal of haematology 187 (1), 117-123, 2019 | 6 | 2019 |
| Fatigued patients with chronic liver disease have subtle aberrations of sleep, melatonin and cortisol circadian rhythms MM Tana, H Alao, N Morris, S Bernstein, J Hattenbach, RB Rehman, ... Fatigue: biomedicine, health & behavior 6 (1), 5-19, 2018 | 6 | 2018 |
| Benralizumab is a well-tolerated and effective treatment for PDGFRA-negative hypereosinophilic syndrome (Oral Poster 1) FL Kuang, F Legrand, MA Makiya, S Panch, J Ware, L Wetzler, T Brown, ... 10th Biennial Symposium of the International Eosinophil Society (IES), 19-23, 2017 | 6 | 2017 |
| Serum microRNA-122 and miR-155 as biomarkers of liver injury and inflammation in models of acute and chronic liver disease S Bala, J Petrasek, S Mundkur, D Catalano, J Ward, I Levin, H Alao, ... | 6 | 2012 |
| Alternative interferons and immunomodulators in the treatment of hepatitis C H Alao, T Jake Liang Liver International 34, 133-138, 2014 | 4 | 2014 |
| Safety of liver biopsy in patients with sickle cell related liver disease–a single center experience A Vittal, H Alao, J Hercun, B Sharma, A Khan, D Sharma, W Lee, ... American journal of hematology 97 (7), E257, 2022 | 3 | 2022 |
| Tu1725 Deficiency of Adenosine Deaminase 2 (DADA2); A Rare Cause of Hepatoportal Sclerosis and Non-Cirrhotic Portal Hypertension H Alao, D Kleiner, MAT Han, V Takyar, D Stone, P Hoffmann, A Ombrello, ... Gastroenterology 150 (4), S1172-S1173, 2016 | 2 | 2016 |
| During HCV DAA therapy plasma Mip1B, IP10, and miRNA profile are distinctly associated with subsequent diagnosis of hepatocellular carcinoma: a pilot study S Damjanovska, H Alao, E Zebrowski, C Kowal, L Kostadinova, ... Biology 11 (9), 1262, 2022 | 1 | 2022 |
| Rapid decline in interferon stimulated genes in prior HCV non-responders re-treated with direct acting antivirals H Alao, YJ Kim, EC Wright, M Cam, EM Rivera, N Fryzek, DE Kleiner, ... Hepatology 62, 321A-322A, 2015 | 1 | 2015 |
